We're on a mission

To improve the care and outcomes of people with kidney disease worldwide through the development and implementation of global clinical practice guidelines.

What we do

KDIGO is a global organization developing and implementing evidence-based clinical practice guidelines in kidney disease. It is an independent, volunteer-led, self-managed foundation incorporated in Belgium and accountable to the public and the patients it serves.

KDIGO has a network of dedicated volunteers from around the world who promote awareness, dissemination, adoption, and clinical integration of KDIGO Guidelines both globally and in their respective countries or regions.

KDIGO has a small but energetic core staff who facilitate its work across the globe.

John Davis
Chief Executive Officer

Danielle Green
Executive Director

Melissa Thompson
Chief Operating Officer

Michael Cheung
Chief Scientific Officer

Amy Earley
Guideline Development Director

Jennifer King
Director of Medical Writing

Tanya Green
Events Director

Coral Cyzewski
Events Coordinator

Kathleen Conn
Director of Communications

  1. Guidelines

    KDIGO guidelines translate scientific advances into useful and practical clinical practice recommendations and observations.

  2. Conferences

    KDIGO regularly convenes Controversies Conferences which bring together expert thought leaders to discuss and debate nephrology-related issues not yet fully resolved.

  3. Implementation

    KDIGO implementation activities include sessions at society congresses, stand-alone KDIGO meetings, summits, expert roundtables, implementation kits, speaker tours and more.


Open Call for KDIGO Methods Committee Nominations

KDIGO is issuing an open call for candidates to serve on its Methods Committee. The KDIGO Methods Committee is a group of methodologists and/or nephrologists who provide oversight and guidance to KDIGO Guideline Work Groups in line with the KDIGO Methods Manual for Guideline Development. Their focus is on ensuring the scientific rigor of the guideline development process, addressing new methodological issues as they arise, and maintaining consistency across all KDIGO guidelines. The Methods Committee meets once per month throughout the year.

Candidates may self-nominate or submit nominations on behalf of their peers. Qualified candidates should have experience with guideline development methodology, systematic review, evidence synthesis, and experience in the field of clinical nephrology.

Anyone interested in serving on the KDIGO Methods Committee or who has a candidate to submit for nomination should email [email protected] with a brief description of their interest and the candidate’s CV. The deadline for submissions is September 22, 2023.

KDIGO Methods Manual for Guideline Development

The KDIGO Methods Manual for Guideline Development provides a comprehensive overview of the processes and evidence review methods that serve as the basis for developing and updating KDIGO Guidelines.

The manual was developed by the KDIGO Methods Committee, led by Marcello Tonelli, MD (Canada), and KDIGO Guideline Development Director, Amy Earley (United States), to explain the process of KDIGO guideline development from topic prioritization to publication. Graphics and links throughout the Methods Manual offer examples and support descriptions of often complex processes. The Methods Manual defines and explains each step in these processes, including (but not limited to) topic selection, appointment of guideline Co-Chairs and Work Group members, disclosures of interest, Scope of Work development, selecting an evidence review team, evidence review steps, format for writing guidelines, public review of the draft guideline, publication, implementation, and guideline updates. The manual is not intended as a handbook for conducting a systematic review or developing independent guidelines.

Download the KDIGO Methods Manual for Guideline Development

Our History

Kidney Disease: Improving Global Outcomes (KDIGO) was originally established in 2003 by the National Kidney Foundation, a U.S. foundation experienced in developing and implementing guidelines. In 2013 KDIGO became an independently incorporated non-profit foundation, and is governed by an international volunteer Executive Committee.

Read more about KDIGO in our 2018 Annual Report.

Executive Committee

KDIGO is governed by a volunteer Executive Committee made up of leading nephrology experts from around the globe that are also part of the Global Network. They make critical decisions about KDIGO priorities, projects, and resource allocations.

The 2023 Executive Committee Members are:

  • Michel Jadoul BELGIUM • Co-Chair
  • Morgan Grams UNITED STATES • Co-Chair
  • Paul Stevens UNITED KINGDOM • Treasurer
  • Gloria Ashuntantang CAMEROON
  • Sunita Bavanandan MALAYSIA
  • John Davis UNITED STATES
  • Michelle Denburg UNITED STATES
  • Irene de Lourdes Noronha BRAZIL
  • Jenny Flythe UNITED STATES
  • Masafumi Fukagawa JAPAN
  • Joachim Ix UNITED STATES
  • Meg Jardine AUSTRALIA
  • Markus Ketteler GERMANY
  • Michelle O’Shaughnessy IRELAND
  • Patrick Rossignol MONACO
  • Rita Suri CANADA
  • Sydney Tang HONG KONG
  • Irma Tchokhonelidze GEORGIA
  • Marcello Tonelli CANADA
  • Wolfgang Winkelmayer UNITED STATES

Strategic Partners

KDIGO depends on volunteer and corporate support to educate the global kidney community and improve outcomes for patients all over the world. They build knowledge and awareness through KDIGO and are recognized here for their donations. KDIGO Partners provide general, strategic support to the KDIGO Foundation, as well as direct support to specific programs, such as Controversies Conferences and development of Educational Resources. KDIGO does not elicit corporate support for Clinical Practice Guidelines.